What is NDC 0173-0521?

0173-0521 is the product NDC for Serevent Diskus (salmeterol xinafoate), Salmeterol xinafoate 50 ug/1 powder, metered, listed with the FDA by GlaxoSmithKline LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Serevent Diskus (Salmeterol xinafoate).

GlaxoSmithKline LLC, NDC labeler code 0173. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Serevent Diskus?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Serevent Diskus NDC 0173-0521 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0173-0521Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00173-0521Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0173-0521-00	00173052100	1 INHALER in 1 CARTON (0173-0521-00) / 60 POWDER, METERED in 1 INHALERMarketed from Nov 25, 1997

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Serevent DiskusSuffix: DISKUS
Generic name (nonproprietary): salmeterol xinafoate
Active ingredients: Salmeterol xinafoate — 50 ug/1
Dosage form: Powder, Metered
Route: Oral, Respiratory (Inhalation)
Labeler: GlaxoSmithKline LLCNDC labeler code 0173
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 020692
Marketing start: Nov 25, 1997
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic beta2-Agonists (Mechanism)
Identifiers: Product ID 0173-0521_58899d4d-8769-43e0-94aa-3002f4097f9aSPL ID 58899d4d-8769-43e0-94aa-3002f4097f9aSPL set ID 12d9728e-6b5c-4aee-bfb0-745e542ed2e4RxCUI 866048, 866049UNII 6EW8Q962A5
Pharmacologic class: beta2-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N400173052100 followed by a unit qualifier and the quantity

Package 00173-0521-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 10, 2022. This label includes a boxed warning.

Indications (excerpt from the label)

SEREVENT DISKUS is a LABA indicated for: • Treatment of asthma in patients aged 4 years and older with an ICS. ( 1.1 ) • Prevention of exercise-induced bronchospasm (EIB) in patients aged 4 years and older. ( 1.2 ) • Maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD). ( 1.3 ) Important limitation of use: Not indicated for relief of acute bronchospasm. ( 1.1 , 1.3 ) 1.1 Treatment of Asthma SEREVENT DISKUS is indicated for the treatment of asthma and in the prevention of bronchospasm only as concomitant therapy with an ICS in patients aged 4 years and older with reversible obstructive airway disease, including patients with symptoms of nocturnal …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0173-0521

What is NDC 0173-0521?: 0173-0521 is the product NDC for Serevent Diskus (salmeterol xinafoate), Salmeterol xinafoate 50 ug/1 powder, metered, listed with the FDA by GlaxoSmithKline LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Serevent Diskus (Salmeterol xinafoate).
What is the active ingredient?: Salmeterol xinafoate.
Who is the labeler?: GlaxoSmithKline LLC, NDC labeler code 0173. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Serevent Diskus?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Serevent Diskus (Salmeterol xinafoate) NDC 0173-0521